loadpatents
name:-0.024996995925903
name:-0.017518043518066
name:-0.00996994972229
Pedram; Bijan Patent Filings

Pedram; Bijan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pedram; Bijan.The latest application filed is for "heterocycle amines and uses thereof".

Company Profile
8.19.24
  • Pedram; Bijan - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
Grant 11,413,274 - Zhi , et al. August 16, 2
2022-08-16
Heterocycle Amines And Uses Thereof
App 20220119413 - Ho; Koc-Kan ;   et al.
2022-04-21
Heterocycle amines and uses thereof
Grant 11,186,593 - Ho , et al. November 30, 2
2021-11-30
Methods And Compositions Associated With The Granulocyte Colony-stimulating Factor Receptor
App 20210046045 - Zhi; Lin ;   et al.
2021-02-18
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
Grant 10,736,875 - Zhi , et al. A
2020-08-11
Sulfide alkyl compounds for HBV treatment
Grant 10,710,959 - Chen , et al.
2020-07-14
Heterocycle Amines And Uses Thereof
App 20200216468 - Ho; Koc-Kan ;   et al.
2020-07-09
Heterocycle amines and uses thereof
Grant 10,604,533 - Ho , et al.
2020-03-31
Sulfide Alkyl Compounds For Hbv Treatment
App 20190202780 - Chen; Austin ;   et al.
2019-07-04
Sulfide alkyl compounds for HBV treatment
Grant 10,196,351 - Chen , et al. Fe
2019-02-05
Methods And Compositions Associated With The Granulocyte Colony-stimulating Factor Receptor
App 20180369197 - Zhi; Lin ;   et al.
2018-12-27
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
Grant 10,111,859 - Zhi , et al. October 30, 2
2018-10-30
Heterocycle Amines And Uses Thereof
App 20180298031 - Ho; Koc-Kan ;   et al.
2018-10-18
Heterocycle amines and uses thereof
Grant 10,030,034 - Ho , et al. July 24, 2
2018-07-24
Sulfide Alkyl Compounds For Hbv Treatment
App 20170298014 - Chen; Austin ;   et al.
2017-10-19
Hematopoietic growth factor mimetic small molecule compounds and their uses
Grant 9,622,991 - Zhi , et al. April 18, 2
2017-04-18
Sulfide alkyl compounds for HBV treatment
Grant 9,597,332 - Chen , et al. March 21, 2
2017-03-21
Methods And Compositions Associated With The Granulocyte Colony-stimulating Factor Receptor
App 20160374989 - Zhi; Lin ;   et al.
2016-12-29
Heterocycle Amines And Uses Thereof
App 20160347767 - Ho; Koc-Kan ;   et al.
2016-12-01
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
Grant 9,492,430 - Zhi , et al. November 15, 2
2016-11-15
Sulfide Alkyl Compounds For Hbv Treatment
App 20160151375 - Chen; Austin ;   et al.
2016-06-02
Heterocycle amines and uses thereof
Grant 9,266,874 - Ho , et al. February 23, 2
2016-02-23
Hematopoietic growth factor mimetic small molecule compounds and their uses
Grant 9,144,557 - Zhi , et al. September 29, 2
2015-09-29
Hematopoietic Growth Factor Mimetic Small Molecule Compounds And Their Uses
App 20150252043 - Zhi; Lin ;   et al.
2015-09-10
Androgen Receptor Modulator Compounds And Methods
App 20150099720 - Zhi; Lin ;   et al.
2015-04-09
Methods And Compositions Associated With The Granulocyte Colony-stimulating Factor Receptor
App 20140296292 - Zhi; Lin ;   et al.
2014-10-02
Heterocycle Amines And Uses Thereof
App 20140155379 - Ho; Koc-Kan ;   et al.
2014-06-05
Androgen Receptor Modulator Compounds And Methods
App 20140005186 - Zhi; Lin ;   et al.
2014-01-02
Androgen receptor modulator methods
Grant 8,580,811 - Pedram , et al. November 12, 2
2013-11-12
Hematopoietic Growth Factor Mimetic Small Molecule Compounds And Their Uses
App 20120295904 - Zhi; Lin ;   et al.
2012-11-22
Androgen receptor modulator compounds and methods
App 20120165362 - Pedram; Bijan ;   et al.
2012-06-28
Androgen receptor modulator compounds
Grant 8,193,357 - Pedram , et al. June 5, 2
2012-06-05
Androgen Receptor Modulator Compounds and Methods
App 20090264455 - Pedram; Bijan ;   et al.
2009-10-22
Androgen Receptor Modulator Compounds and Methods
App 20090227571 - Loren; Jon C. ;   et al.
2009-09-10
Androgen Receptor Modulator Compounds and Methods
App 20090030027 - Pedram; Bijan ;   et al.
2009-01-29
Androgen Receptor Modulator Compounds and Methods
App 20070254875 - Zhi; Lin ;   et al.
2007-11-01
5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
Grant 7,163,946 - Zhi , et al. January 16, 2
2007-01-16
5-Cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
App 20060194827 - Zhi; Lin ;   et al.
2006-08-31
5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
Grant 7,071,205 - Zhi , et al. July 4, 2
2006-07-04
5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
App 20040152718 - Zhi, Lin ;   et al.
2004-08-05
5-Substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
App 20040152717 - Zhi, Lin ;   et al.
2004-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed